With Sleep Medicine Launch, Wolters Kluwer Expands UpToDate Coverage to 24 Specialties
9.8.2016 13:30 | Business Wire
The Health division of Wolters Kluwer , a leading global provider of information and point-of-care solutions for the healthcare industry, announced today that it has added sleep medicine to UpToDate ® , its evidence-based clinical decision support resource. Sleep medicine marks the 24th medical specialty available to subscribing clinicians and healthcare institutions around the world.
While core sleep medicine topics were first developed in UpToDate over a decade ago, the addition of sleep medicine as a formal specialty is the result of more than three years of collaboration, led by UpToDate Sleep Medicine Editors-in-Chief Ronald D. Chervin, MD, MS and Nancy Collop, MD. They led a team of 84 prominent sleep medicine specialists to develop and expand the new specialty.
“Dr. Chervin and I were able to assemble the ‘A’ team to develop sleep medicine content in UpToDate,” said Dr. Collop. “UpToDate users will find the information on sleep medicine to be comprehensive, providing them with evidence-based content they need to care for patients with sleep complaints or sleep disorders.”
Clinicians using UpToDate can be confident they are integrating into their clinical practice the most current and wide-ranging information about sleep medicine. The continuously updated diagnostic information and treatment recommendations in UpToDate cover sleep-related breathing and movement disorders, insomnia, circadian rhythm sleep-wake disorders, parasomnias, and more, with content tailored to both adult and pediatric patients.
Specialists in pulmonary and critical care medicine, neurology, psychiatry, geriatrics, surgery and anesthesiology, as well as primary care internists, family medicine physicians, and pediatricians will also benefit from the expanded sleep medicine content now available in UpToDate.
Authored by leading sleep medicine experts from around the world, the new specialty spans 90 topics with over 70 graded recommendations. Professional topics are complemented by easy-to-read patient information topics, nearly 75% of which will also be available in Spanish. The specialty also includes over 260 graphics, ranging from pictures and tables to figures, graphs, algorithms and more. Sleep medicine content in UpToDate includes peer-reviewed, evidence-based recommendations that reflect the latest medical advances and practices from leading medical journals, including Journal of Clinical Sleep Medicine, Journal of Sleep Research, Sleep, Sleep Medicine, Sleep Medicine Review and others.
“Wolters Kluwer remains steadfast in its efforts to further develop the breadth and depth of rich clinical content clinicians trust to provide the very best care for their patients,” said Peter Bonis, MD, Chief Medical Officer, Clinical Effectiveness, Wolters Kluwer. “For sleep medicine specialists and additional healthcare providers around the world, the launch of our 24th specialty affirms that commitment to providing the most comprehensive, evidence-based recommendations available for treating patients.”
The new specialty is available now to subscribers at www.uptodate.com. For clinicians who rely on tablets and smartphones as mobile health tools, they can also find answers to clinical questions in the office, clinic or field by using the UpToDate mobile app. Available for iOS® and Android™ mobile platforms, the mobile app includes options to access all UpToDate content with or without an internet connection. Learn more at http://www.uptodate.com/home/uptodate-mobile-apps
About Wolters Kluwer
Wolters Kluwer N.V. (AEX:WKL) is a global leader in information services and solutions for professionals in the health, tax and accounting, risk and compliance, finance and legal sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with specialized technology and services.
Wolters Kluwer reported 2015 annual revenues of €4.2 billion. The company, headquartered in Alphen aan den Rijn, the Netherlands, serves customers in over 180 countries, maintains operations in over 40 countries and employs 19,000 people worldwide.
Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).
Wolters Kluwer Health is a leading global provider of information and point of care solutions for the healthcare industry. For more information about our products and organization, visit http://www.wolterskluwer.com/, follow @WKHealth or @Wolters_Kluwer on Twitter, like us on Facebook, follow us on LinkedIn, or follow WoltersKluwerComms on YouTube.
Wolters Kluwer Health | UpToDate
André Rebelo, +1 781-392-2411
Public & Analyst Relations Manager
Om Business Wire
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
The Valence Group Issues Fairness Opinion to SK Capital in Connection with Archroma18.8.2017 13:30 | Pressemelding
The Valence Group has provided a fairness opinion to SK Capital Partners, LP in connection with its recapitalization of Archroma, including investments made by various affiliates of SK Capital. Terms of the transaction were not disclosed. About SK Capital SK Capital is a private investment firm focused on the specialty materials, chemicals and pharmaceutical sectors. The firm builds strong and growing businesses that generate substantial long-term value for its investors. SK Capital utilizes its industry, operating and investment experience to identify opportunities to transform businesses into higher performing companies with improved strategic positioning, growth, profitability and risk profiles. The firm currently has approximately $1.9 billion of assets under management and its portfolio companies generate revenues of over $5.0 billion annually and employ approximat
Biker Summer 2017 campaign: What’s happening during Biker Summer 2017? Moto-tyres.co.uk is giving away exciting prizes!18.8.2017 09:22 | Pressemelding
Whether it’s a short weekend break or a long-distance tour – once again this year Moto-tyres.co.uk is asking bikers from 10 countries about their dream destinations and longest journeys as part of its “Biker Summer 2017” campaign. To ensure than nothing gets in the way of your next tour, the two-wheeler tyre store from Delticom, Europe’s leading online tyre dealer, is entering anyone who completes the survey before 30 September 2017 into a prize draw to win some great biking accessories. Simply answer three short questions about your plans for bike tours this year (don’t forget to provide your name and email address), and with a bit of luck, you might win one of these great prizes. Up for grabs are a GARMIN motorbike GPS system, a GoPro camera with helmet bracket and five 200-Pound vouchers for new motorbike tyres from the online store – thanks to the product range at Moto-tyres.co.uk, eve
Lenovo Continues to Gain Momentum in First Quarter FY 2017/1818.8.2017 00:04 | Pressemelding
Behind the strength of its 3-wave strategy, Lenovo’s business transformation continued to gain traction during the first quarter, delivering solid profitability in its core PC and smart devices business, and revenue and profit improvements in targeted growth areas, including the data center and mobile businesses. Fueled by new investments in people and products, Lenovo’s Data Center Group (DCG) introduced the most comprehensive product lineup in its history, with the new ThinkSystem and ThinkAgile portfolio, and continued to build out its end-to-end sales organization. Similarly, Lenovo’s Mobile Business Group launched significant new products led by the Moto Z2 Force, available now on all major U.S. carriers, and ramped up its branding efforts worldwide. “In the first quarter this fiscal year, we had stable performance as we executed our 3-wave strategy with commitment. We
Spirent Tests Wi-Fi Network Performance with O2 at the Coca-Cola London Eye17.8.2017 15:57 | Pressemelding
Spirent Communications plc (LSE:SPT), today announced its Landslide E10 network test platform has been used with O2 to validate the Wi-Fi network performance and capacity at the Coca-Cola London Eye, before the launch of a new smartphone application last month. This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170817005758/en/ Spirent Landslide E10 helped O2 validate Wi-Fi performance and capacity at the Coca-Cola London Eye, before the launch of a new smartphone application last month. (Photo: Busines Wire) Merlin Entertainments plc, operator of the London Eye, wanted to measure its Wi-Fi network performance, to ensure its infrastructure could provide an excellent experience for users of the new app, which puts increased demands on the Wi-Fi network. “The London Eye is a global attractio
Watch BizWireTV: A Camera You Can Wear and Krispy Kreme’s Famous Donuts Get Eclipsed with Chocolate17.8.2017 12:08 | Pressemelding
On BizWireTV, catch some Quick Biz Hits and see the latest in Star Power. Also see what’s happening in the startup world with the Accelerator Report, featuring the VC Watch and this week’s Startup Standout. This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170817005305/en/ BizWireTV is hosted by Jordyn Rolling (Photo: Business Wire Now you can watch BizWireTV, and the latest breakthroughs in tech from the biggest brands, on any screen you want by downloading the new app through the Apple TV and iPhone App Store and Google Play for Android devices. Top of the Wire Introducing FrontRow: the camera re-invented. Watch BizWireTV to see more disruptors as well as the top 5 trending stories of the week! A core c
PsiOxus Therapeutics Announce Two New Board Appointments: New Board Appointments Strengthen Company’s US Presence17.8.2017 07:00 | Pressemelding
PsiOxus Therapeutics, Ltd. (PsiOxus) today announced the appointment of Charles Rowland and Duncan Higgons to the Board of Directors as part of an ongoing drive to expand in the US. Charles Rowland was most recently the President and Chief Executive Officer (CEO) of Aurinia Pharmaceuticals, a clinical stage pharmaceutical company focused on the global lupus nephritis market. Prior to this, he served as the Vice President and Chief Financial Officer (CFO) of ViroPharma, during which time the company grew into a global biopharmaceutical business with $500 million in annual revenues until it was acquired by Shire plc for $4.2 billion. Before joining ViroPharma, Mr. Rowland was executive Vice President, CFO, and interim co-CEO, for Endo Pharmaceuticals. In his earlier career, Charles held finance and operational positions at Biovail Pharmaceuticals, Breakaway Technologies, Pharmacia
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom